CoChat

The metabolic consequences of thyroxine replacement in adult hypopituitary patients

Filipsson Nyström, Helena, Feldt-Rasmussen, Ulla, Kourides, Ione, Popovic, Vera, Koltowska-Häggström, Maria, Jonsson, Björn, Johannsson, Gudmundur · 2012 · Pituitary

The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.

Abstract

The metabolic consequences of thyroxine replacement in patients with central hypothyroidism (CH) need to be evaluated. The aim was to examine the outcome of thyroxine replacement in CH. Adult hypopituitary patients (n = 1595) with and without CH from KIMS (Pfizer International Metabolic Database) were studied before and after 2 years of GH replacement. CH patients (CH, n = 1080) were compared with TSH sufficient patients (TSHsuff n = 515) as one group and divided by thyroxine dose/kg/day into tertiles (CHlow-mid-high). Anthropometry, fasting glucose, glycosylated haemoglobin (HbA1c), blood pressure, lipids, IGF-I SDS, quality of life and morbidity were studied. Analyses were standardized for gender, age, number and types of pituitary insufficiencies, stimulated GH peak, age at GH deficiency onset, aetiologies and, when appropriate, for weight and GH dose. At baseline, TSHsuff patients did not differ from CH or CHmid in any outcome. CHlow (≤ 1.18 μg thyroxine/kg/day) had increased weight, BMI and larger waist circumference (WC), CHhigh (≥ 1.58 μg thyroxine/kg/day) had lower weight, BMI, WC and IGF-I than TSHsuff and compared to their predicted weights, BMIs and WCs. For every 0.1 μg/kg/day increase of thyroxine dose, body weight decreased 1.0 kg, BMI 0.3 kg/m(2), and WC 0.65 cm. The GH sensitivity of the CH group was higher (0.76 ± 0.56 SDS/mg GH) than that of TSHsuff patients (0.58 ± 0.64 SDS/mg GH), P < 0.001. The middle thyroxine dose (1.19-1.57 μg/kg/day) seems to be the m…

Overview

Integrity signals

Registry

Crossref · 10.1007/s11102-011-0356-6

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Cited by

See all 19

Metadata

Authors
Filipsson Nyström, H., Feldt-Rasmussen, U., Kourides, I., Popovic, V., Koltowska-Häggström, M., Jonsson, B., & Johannsson, G.
Affiliations
  • Pfizer (United States) (US)
  • University of Belgrade (RS)
  • Sahlgrenska University Hospital (SE)
Venue
Pituitary
Published
2011-10-22
Volume
15
Issue
4
Pages
495-504
ISSN
  • 1386-341X (ISSN-L)
  • 1573-7403
OpenAlex
W2051124804
Cited by
18
References
40
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 2 · 2016: 3 · 2015: 1 · 2014: 1 · 2013: 1
FWCI
0.52
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Pituitary (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
  • Pfizer
  • Sahlgrenska Universitetssjukhuset
  • Sahlgrenska Akademin
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Keywords
thyroxine replacement, central hypothyroidism, growth hormone replacement therapy, body weight, body mass index, waist circumference, insulin-like growth factor I, glycemic control, lipids, blood pressure, quality of life
MeSH terms
Adult, Female, Glycated Hemoglobin, Humans, Hypopituitarism, Male, Middle Aged, Thyroxine, Human Growth Hormone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The metabolic consequences of thyroxine replacement in adult hypopituitary patients. https://app.cochat.ai/papers/10.1007/s11102-011-0356-6
The paper
Filipsson Nyström, H., Feldt-Rasmussen, U., Kourides, I., Popovic, V., Koltowska-Häggström, M., Jonsson, B., & Johannsson, G. (2012). The metabolic consequences of thyroxine replacement in adult hypopituitary patients. Pituitary. https://doi.org/10.1007/s11102-011-0356-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.